Business Wire

Align Technology Launches Align X-ray Insights, an AI Computer-Aided Detection Software, in the European Union and United Kingdom

Share

Align Technology, Inc. (“Align”) (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced the launch in European Union countries and the United Kingdom of Align X-ray Insights, a new software-based (CADe*) computer aided detection solution that uses artificial intelligence (AI) to automatically analyze 2D radiographs.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250310448632/en/

Align X-ray Insights, an AI Computer-Aided Detection Software (Photo: Business Wire)

As part of the Align™ Digital Platform, Align X-ray Insights software is designed to support doctors to diagnose dental and oral health conditions, standardize analysis, streamline workflows, and improve patient engagement. A recent survey among early doctor users of the technology showed it helped 95% of them in communicating patient oral health conditions. Furthermore, 91% agreed that, when shown to patients, it improved patient trust and treatment acceptance of restorative procedures.1

After confirming diagnosis, doctors can use the Align X-ray Insights detailed report, automatic tooth charting, and color overlays of radiographic abnormalities for patient education and treatment planning. The AI detection functionalities include caries, periapical radiolucencies and periodontal bone loss and other conditions.

Align X-ray Insights – alongside Align™ Oral Health Suite, a comprehensive digital suite providing a clinical framework to empower engaging oral health conversations – further reinforces Align’s commitment to dental diagnostics by launching an X-ray diagnostic digital solution that can enhance the already available NIRI (Near Infra-Red Imaging) technology with iTero intraoral scanners and Oral Health Suite’s capabilities, with the objective to support and advance doctor treatment planning decisions and priorities, based on the patient records available.

“Align X-ray Insights represents a significant advancement in our digital restorative dentistry solutions with broader patient applicability,” said Simon Beard, Align Technology executive vice president and managing director, Europe, Middle East, and Africa (EMEA). “By integrating AI into radiographic analysis, we are empowering doctors with more precise diagnostic capabilities to improve their patient outcomes. This launch underscores our commitment to innovation and our ongoing efforts to expand our digital platform.”

“It is fantastic to see Align X-ray Insights being integrated into Align’s digital platform – bringing diagnostic AI capabilities to dentists all over the world. When we started our journey towards AI in dental diagnostics, we had hoped to improve patient outcomes via better diagnostics and treatment decisions,” said Professor Falk Schwendicke, director of the Dental Clinic at University of Munich. “Since then, we learned that further value lies in Align X-ray Insights by fostering patient communication, and facilitating comprehensive, systematic reporting. Combining this with the products and services already available to Align users is a leap forward for digital dentistry.”

Align Technology acquired dentalXrai GmbH in 2022 and has since worked on integrating its flagship product into the Align Digital Platform. Align X-ray Insights, a cloud-based software, can be accessed either from any desktop or tablet or through an integration with iTero. The desktop / tablet version becomes generally available in the European Union and United Kingdom as of March 25, 2025, and will be presented at the IDS tradeshow in Cologne, Germany on March 25-29, 2025. The integration of Align X-ray Insights with iTero™ intraoral scanners is underway and will commence limited market release soon. Align X-ray Insights received regulatory clearance in Europe, the UK, Canada and New Zealand, with further availability in other countries planned, pending approvals such as 510K clearance in the United States of America.

For more information, interested customers can visit www.alignxrayinsights.com. As part of the launch offer, doctors can benefit from a 60-day free-trial.

*CADe = computer-aided detection

  1. Based on a survey of n=24 doctors (19 GP / 5 orthodontists) using Align™ X-ray Insights in Europe (FR, UK, IT, DE, ES, NL, DK and LV) who were part of a limited market release. Doctors indicated their agreement with different statements using a 4-point scale from strongly agree to strongly disagree. Statements included “Align X-ray Insights, when shown to patients, increased treatment acceptance of restorative procedures.” (91% agreement), “Align X-ray Insights streamlines the dental diagnostic workflow, helping me save valuable time.” (70% agreement), “Align X-ray Insights contributes to higher trust when shown to patients during treatment option discussions.” (91% agreement) and “Align X-ray Insights helps me communicate patient oral health conditions and treatment options.” (95% agreement). Align X-ray Insights is intended to be used in conjunction with an evaluation by the doctor and should not be solely relied upon to make or confirm a diagnosis. Data on file at Align Technology as of January 2025.

About Align Technology, Inc.

Align Technology designs and manufactures the Invisalign® System, iTero™ intraoral scanners and services, and exocad™ CAD/CAM software. These technology building blocks enable enhanced digital orthodontic and restorative workflows to improve patient outcomes and practice efficiencies for over 271.6 thousand doctor customers and is key to accessing Align’s 600 million consumer market opportunity worldwide. Over the past 28 years, Align has helped doctors treat approximately 19.5 million patients with the Invisalign System and is driving the evolution in digital dentistry through the Align™ Digital Platform, our integrated suite of unique, proprietary technologies and services delivered as a seamless, end-to-end solution for patients and consumers, orthodontists and GP dentists, and lab/partners. Visit www.aligntech.com for more information.

For additional information about the Invisalign System or to find an Invisalign doctor in your area, please visit www.invisalign.com. For additional information about the iTero digital scanning system, please visit www.itero.com. For additional information about exocad dental CAD/CAM offerings and a list of exocad reseller partners, please visit www.exocad.com.

Invisalign, iTero, exocad, Align, and Align Digital Platform are trademarks of Align Technology, Inc.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250310448632/en/

Contacts

Align Technology
Madelyn Valente
(909) 833-5839
mvalente@aligntech.com

Zeno Group
Sarah Karlson
(828) 551-4201
sarah.karlson@zenogroup.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

www.businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

SCENTMATIC's AI "KAORIUM" Debuts at THAMEEN Fragrance Launch in London's Selfridges4.7.2025 12:13:00 EEST | Press release

SCENTMATIC Inc., a leader in scent digitalization, introduced its AI-powered scent-to-language system, KAORIUM, at the THAMEEN Fragrance new product launch event. This pivotal event took place from June 5 to 11, 2025, at Selfridges department store in London, UK. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250703662207/en/ State of exhibition Global Expansion: KAORIUM Establishes UK Presence Europe leads the global fragrance market, with the UK projected to reach US$2.82 billion by 2033. Recognizing this, SCENTMATIC is rapidly expanding its international footprint. In May 2024, SCENTMATIC established its overseas subsidiary, KAORIUM, in London, appointing industry expert Ben Yanoushek as CEO. Official UK operations commenced on February 1, 2025, with the launch of its dedicated website: www.kaorium.com. KAORIUM Trialed at "Florentine Diamond" Launch Event The "Florentine Diamond" launch event for luxury brand THAMEEN Frag

Global Tourism Surging Ahead of Economic Growth, With Visits to Hit 30 Billion by 20344.7.2025 02:00:00 EEST | Press release

The World Economic Forum has today published a new report forecasting that the travel and tourism industry is projected to serve 30 billion tourist trips by 2034. Travel and Tourism at a Turning Point: Principles for Transformative Growth, produced in collaboration with Kearney and the Ministry of Tourism Saudi Arabia, reveals a projected $16 trillion contribution to global GDP by the same year—representing more than 11% of the total world economy, according to World Travel & Tourism Council estimates. The report also found that the sector is expanding 1.5 times faster than the global economy, generating significant commercial opportunities as long as the mounting challenges of climate change, labour shortages and infrastructure gaps are addressed. Inbound and outbound trips increasing fast Asia is on track to become the world’s fastest-growing tourism economy, with the direct travel and tourism GDP contribution expected to exceed 7% across the region by 2034. Notably, India and China

The 2025-2026 World Branding Awards Animalis Edition Honouring Leading Pet and Animal Brands Globally3.7.2025 22:00:00 EEST | Press release

The 2025-2026 World Branding Awards Animalis Edition marked its fifth instalment, bringing together leading pet and animal brands from all around the world. These brands were celebrated for their outstanding achievements, earning recognition as National, Regional, and Global Winners. The awards ceremony, held at Vienna's prestigious Hofburg Palace, welcomed winners across diverse categories, including pet food, retail, wellness, pet exhibitions, and aquatic products. Mounia Berrada-Gouzi expertly hosted the evening, which culminated in a grand celebration of brand excellence. “The Animalis Edition of the World Branding Awards recognises brands that have achieved the highest distinction—genuine recognition in the hearts and minds of consumers. Tonight, we honour those whose names resonate globally, whose values inspire loyalty, and whose presence defines excellence in the pet and animal industry,” said Richard Rowles, Chairman of the World Branding Forum. Out of over 950 brands nominate

Venture Global Announces 20-Year Sales and Purchase Agreement with PETRONAS3.7.2025 15:59:00 EEST | Press release

Today, Venture Global, Inc. (NYSE: VG) announced the execution of a new 20-year Sales and Purchase Agreement (SPA) with PETRONAS LNG Ltd. (PLL), a subsidiary of the Malaysian state-owned oil and gas company, PETRONAS. Under the terms of the SPA, PETRONAS will purchase 1 million tonnes per annum (MTPA) of liquefied natural gas (LNG) from Venture Global’s third facility, CP2 LNG, for 20 years. This builds upon Venture Global’s existing agreement with PETRONAS for 1 MTPA of LNG supply from Plaquemines LNG. PETRONAS, a world-class partner in the LNG industry, joins other CP2 LNG customers in Europe, Asia and the rest of the world in a strategically important project to global energy supply and security. To date, approximately 10.75 MTPA of the 14.4 MTPA nameplate capacity for CP2 Phase One has been sold. About Venture Global Venture Global is a long-term, low-cost provider of U.S. LNG sourced from resource rich North American natural gas basins. Venture Global’s business includes assets ac

Frost & Sullivan Recognizes Novotech as 2025 Global Biotech CRO Company of the Year3.7.2025 15:05:00 EEST | Press release

In recognition of its innovation, client-focused delivery, and global impact, Novotech has been awarded the 2025 Global Biotechnology Contract Research Organization (CRO) Company of the Year by Frost & Sullivan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250703950144/en/ Novotech Wins Global CRO Award Novotech is a globally recognized full-service clinical CRO and scientific advisory firm, trusted by biotech and small- to mid-sized pharmaceutical companies to advance their drug development programs at every phase. With a global footprint spanning Asia-Pacific, North America, and Europe, Novotech supports over 5,000 clinical trial sites and a distributed team of experts delivering seamless, end-to-end solutions across geographies. “Novotech is redefining biotech-focused clinical research through AI-driven innovation, global expansion, and a client-embedded partnership model. With a clear vision to be the CRO of choice for

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye